The frequency of founder mutations in the BRCA1, BRCA2, and APC genes in Australian Ashkenazi Jews: Implications for the generality of U.S. Population data

Cancer

Volumn 92, Issue 2, 2001, Pages 440-445

  Bahar, Anita Y ^a   Taylor, Peter J ^a   Andrews, Lesley ^a   Proos, Anne ^b   Burnett, Leslie ^b   Tucker, Katherine ^a   Friedlander, Michael ^a   Buckley, Michael F ^a  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

Ashkenazim; Australia; BRCA1; BRCA2; Founder mutations; Jewish

Indexed keywords

ADOLESCENT; ADULT; ALLELE; ARTICLE; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENE FREQUENCY; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRATION; ONCOGENE; PRIORITY JOURNAL; RACE DIFFERENCE; RELIGIOUS GROUP; SCREENING TEST; TAY SACHS DISEASE;

ADULT; AGED; AGED, 80 AND OVER; AUSTRALIA; BRCA2 PROTEIN; BREAST NEOPLASMS; CARCINOMA; DNA MUTATIONAL ANALYSIS; EMIGRATION AND IMMIGRATION; FEMALE; FOUNDER EFFECT; GENES, APC; GENES, BRCA1; HUMANS; JEWS; MASS SCREENING; MIDDLE AGED; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; REFERENCE VALUES; UNITED STATES;

EID: 0035878629     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20010715)92:2<440::AID-CNCR1340>3.0.CO;2-O     Document Type: Article

References (28)

1. Genetic analysis of idiopathic torsion dystonia in Ashkenazi Jews and their recent descent from a small founder population
2. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews
3. Breast and ovarian cancer incidence in BRCA1-mutation carriers
4. Linkage of early-onset familial breast cancer to chromosome 17q21
5. Familial breast-ovarian cancer locus on chromosome 17q12-q23
6. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1
7. Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families
8. BRCA1 required for transcription-coupled repair of oxidative DNA damage
9. Association of BRCA1 with Rad 51 in mitotic and meiotic cells
10. BRCA1, BRCA2 and RAD51 operate in a common DNA damage response pathway
11. The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRC42 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women
12. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRC42
13. Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: Frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families
14. Identification of the breast cancer susceptibility gene BRCA2
15. The BRC repeats in BRCA2 are critical for RAD51 binding and resistance to methyl methane sulfonate treatment
16. Population genetics of BRCA1 and BRCA2
17. Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: Results of an international study
18. Lessons from hereditary colorectal cancer
19. Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC
20. The APC variants I1307K and E1307Q are associated with colorectal tumors, but not always with a family history
21. The I1307 polymorphism of the APC gene in colorectal cancer
22. The APC I1307K allele and cancer risk in a community-based study of Ashkenazi Jews
23. I1307K APC and hMLH1 mutations in a non-Jewish family with hereditary non-polyposis colorectal cancer
24. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS)
25. Age-related differences in heterozygote frequencies of mutations commonly found in the Ashkenazi Jewish population
26. BRCA2 in American families with four or more cases of breast or ovarian cancer: Recurrent and novel mutations, variable expression, penetrance, and the possibility of families whose cancer is not attributable to BRCA1 or BRCA2